Business Standard

Delhi High Court asks Singh brothers to pay up Rs 35 bn to Daiichi

Enforces arbitration award related to the $4.6-bn sale of Ranbaxy

Delhi High Court asks Singh brothers to pay up Rs 35 bn to Daiichi
Premium

Veena ManiBloomberg
Malvinder Singh and Shivinder Singh, promoters of Fortis Healthcare, need to pay Japanese drug maker Daiichi Sankyo Rs 35 billion ($550 million), awarded in arbitration over the $4.6-billion sale of Ranbaxy Laboratories to Daiichi in 2008.

The verdict was pronounced by the Delhi High Court’s single-judge bench of Justice Jayant Nath. He rejected all objections raised by the Singh brothers and said the arbitration award was in line with Indian laws and policy. The ruling can still be appealed in a two-member panel of the Delhi HC or the Supreme Court.

The Japanese firm had moved the Delhi HC to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in